Harvard Bioscience Inc (NASDAQ: HBIO) kicked off on Friday, down -4.84% from the previous trading day, before settling in for the closing price of $0.52. Over the past 52 weeks, HBIO has traded in a range of $0.28-$3.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -18.10%. While this was happening, its average annual earnings per share was recorded 0.00%. With a float of $37.92 million, this company’s outstanding shares have now reached $44.53 million.
Harvard Bioscience Inc (HBIO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Harvard Bioscience Inc is 14.85%, while institutional ownership is 43.69%.
Harvard Bioscience Inc (HBIO) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.02 earnings per share (EPS), lower than consensus estimate (set at 0.01) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.04 per share during the current fiscal year.
Harvard Bioscience Inc (NASDAQ: HBIO) Trading Performance Indicators
Take a look at Harvard Bioscience Inc’s (HBIO) current performance indicators. Last quarter, stock had a quick ratio of 0.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.25. Likewise, its price to free cash flow for the trailing twelve months is 5.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.30, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.15 in one year’s time.
Technical Analysis of Harvard Bioscience Inc (HBIO)
The latest stats from [Harvard Bioscience Inc, HBIO] show that its last 5-days average volume of 0.65 million was inferior to 4.86 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 47.22%.
During the past 100 days, Harvard Bioscience Inc’s (HBIO) raw stochastic average was set at 31.96%, which indicates a significant increase from 27.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0379 in the past 14 days, which was lower than the 0.0581 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4845, while its 200-day Moving Average is $0.9992. Now, the first resistance to watch is $0.5182. This is followed by the second major resistance level at $0.5415. The third major resistance level sits at $0.5576. If the price goes on to break the first support level at $0.4788, it is likely to go to the next support level at $0.4627. The third support level lies at $0.4394 if the price breaches the second support level.
Harvard Bioscience Inc (NASDAQ: HBIO) Key Stats
The company with the Market Capitalisation of 22.04 million has total of 44,531K Shares Outstanding. Its annual sales at the moment are 94,140 K in contrast with the sum of -12,410 K annual income. Company’s last quarter sales were recorded 20,450 K and last quarter income was -2,280 K.
